Timothy Chan
18Patents
5h-index
40Co-inventors
62Inventor score
Filing activity: Sep 7, 2007 → Aug 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8293923B2 | Indazole derivatives as modulators of interleukin-1 receptor-associated kinase | Chemistry; Metallurgy | 23 | Active |
| US9809577B2 | Biaryl inhibitors of Bruton's tyrosine kinase | Chemistry; Metallurgy | 10 | Active |
| US10081619B2 | Biaryl inhibitors of bruton's tyrosine kinase | Chemistry; Metallurgy | 7 | Active |
| US9394277B2 | Pyrimidinyl tyrosine kinase inhibitors | Human Necessities | 6 | Active |
| US9353087B2 | Inhibitors of Bruton's tyrosine kinase | Chemistry; Metallurgy | 5 | Active |
| US9771326B2 | S1P and/or ATX modulating agents | Chemistry; Metallurgy | 5 | Active |
| US9850206B2 | S1P and/or ATX modulating agents | Chemistry; Metallurgy | 4 | Active |
| US10246456B2 | IRAK4 inhibiting agents | Chemistry; Metallurgy | 3 | Active |
| US10759783B2 | Biaryl inhibitors of Bruton'S tyrosine kinase | Chemistry; Metallurgy | 3 | Active |
| US9944622B2 | Pyrimidinyl tyrosine kinase inhibitors | Human Necessities | 3 | Active |
| US9546165B2 | Heterocyclic compounds useful as PDK1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10280169B2 | Biaryl bruton's tyrosine kinase inhibitors | Physics | 0 | Active |
| US10618887B2 | Pyrimidinyl tyrosine kinase inhibitors | Human Necessities | 0 | Active |
| US11427561B2 | IRAK4 inhibiting agents | Human Necessities | 0 | Active |
| US10189817B2 | Inhibitors of Bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US11572356B2 | Biaryl inhibitors of Bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US10030016B2 | Heterocyclic compounds useful as PDK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10577367B2 | IRAK4 inhibiting agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.